Allelic and genotypic associations of DRD2 Taq I A polymorphism with heroin dependence in Spanish subjects: a case control study
| dc.contributor.author | Pérez de los Cobos Peris, José C. | |
| dc.contributor.author | Baiget Bastús, Montserrat | |
| dc.contributor.author | Trujols i Albet, Joan | |
| dc.contributor.author | Sinol, Nuria | |
| dc.contributor.author | Volpini Bertrán, Víctor | |
| dc.contributor.author | Banuls, Enrique | |
| dc.contributor.author | Calafell, Francesc | |
| dc.contributor.author | Luquero, Elena | |
| dc.contributor.author | Rio, Elisabeth del | |
| dc.contributor.author | Alvarez, Enric | |
| dc.date.accessioned | 2018-11-23T14:14:44Z | |
| dc.date.available | 2018-11-23T14:14:44Z | |
| dc.date.issued | 2007-06-01 | |
| dc.date.updated | 2018-07-25T10:44:29Z | |
| dc.description.abstract | Background: Conflicting associations with heroin dependence have been found involving the A1 allele of dopamine D2 receptor gene ( DRD2) TaqI A polymorphism. Methods: We compared two samples of unrelated Spanish individuals, all of European origin: 281 methadone-maintained heroin-dependent patients ( 207 males and 74 females) who frequently used non-opioid substances, and 145 control subjects ( 98 males and 47 females). Results: The A1-A1 genotype was detected in 7.1% of patients and 1.4% of controls ( P = 0.011, odds ratio = 5.48, 95% CI 1.26-23.78). Although the A1 allele was not associated with heroin dependence in the entire sample, the frequency of A1 allele was higher in male patients than in male controls ( 24.4% vs. 16.3%, P = 0.024, odds ratio = 1.65, 95% CI 1.07-2.57). A logistic regression analysis showed an interaction between DRD2 alleles and gender ( odds ratio = 1.77, 95% CI 1.15-2.70). Conclusion: Our results indicate that, in Spanish individuals, genotypes of the DRD2 TaqI A polymorphism contribute to variations in the risk of heroin dependence, while single alleles contribute only in males. | |
| dc.format.extent | 6 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.pmid | 17543096 | |
| dc.identifier.uri | https://hdl.handle.net/2445/126407 | |
| dc.language.iso | eng | |
| dc.publisher | BioMed Central | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1186/1744-9081-3-25 | |
| dc.relation.ispartof | Behavioral and Brain Functions, 2007, vol. 3, num. 25 | |
| dc.relation.uri | https://doi.org/10.1186/1744-9081-3-25 | |
| dc.rights | cc by (c) Pérez de los Cobos Peris et al., 2007 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
| dc.subject.classification | Heroïna | |
| dc.subject.classification | Metadona | |
| dc.subject.other | Heroin | |
| dc.subject.other | Methadone hydrochloride | |
| dc.title | Allelic and genotypic associations of DRD2 Taq I A polymorphism with heroin dependence in Spanish subjects: a case control study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1